Abstract |
α- Synuclein is the major component of filamentous inclusions that constitute the defining characteristic of neurodegenerative α- synucleinopathies. However, the molecular mechanisms underlying α- synuclein accumulation and spread are unclear. Here we show that intracerebral injections of sarkosyl-insoluble α- synuclein from brains of patients with dementia with Lewy bodies induced hyperphosphorylated α- synuclein pathology in wild-type mice. Furthermore, injection of fibrils of recombinant human and mouse α- synuclein efficiently induced similar α- synuclein pathologies in wild-type mice. C57BL/6J mice injected with α- synuclein fibrils developed abundant Lewy body/Lewy neurite-like pathology, whereas mice injected with soluble α- synuclein did not. Immunoblot analysis demonstrated that endogenous mouse α- synuclein started to accumulate 3 months after inoculation, while injected human α- synuclein fibrils disappeared in about a week. These results indicate that α- synuclein fibrils have prion-like properties and inoculation into wild-type brain induces α- synuclein pathology in vivo. This is a new mouse model of sporadic α- synucleinopathy and should be useful for elucidating progression mechanisms and evaluating disease-modifying therapy.
|
Authors | Masami Masuda-Suzukake, Takashi Nonaka, Masato Hosokawa, Takayuki Oikawa, Tetsuaki Arai, Haruhiko Akiyama, David M A Mann, Masato Hasegawa |
Journal | Brain : a journal of neurology
(Brain)
Vol. 136
Issue Pt 4
Pg. 1128-38
(Apr 2013)
ISSN: 1460-2156 [Electronic] England |
PMID | 23466394
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Prions
- Recombinant Proteins
- SNCA protein, human
- Snca protein, mouse
- alpha-Synuclein
|
Topics |
- Administration, Intranasal
- Animals
- Behavior, Animal
(physiology)
- Brain
(metabolism, pathology, physiopathology)
- Disease Models, Animal
- Female
- Humans
- Injections, Intraventricular
- Lewy Body Disease
(metabolism, pathology, physiopathology)
- Mice
- Mice, Inbred C57BL
- Prions
(metabolism)
- Recombinant Proteins
(administration & dosage, toxicity)
- Time Factors
- alpha-Synuclein
(administration & dosage, metabolism, toxicity)
|